Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1976 Jul 10;2(6027):79–83. doi: 10.1136/bmj.2.6027.79

Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.

R B Naik, P Gosling, C P Price, B H Robinson, J T Dabek, D A Heath, H M James, J A Kanis, R Smith
PMCID: PMC1687833  PMID: 1276820

Abstract

Four selected adults with different patterns of osteodystrophy receiving regular dialysis were treated with 1-alpha-hydroxycholecalciferol (1-alpha-OHD3) 0-5-2 mug/day for 10 to 12 months. In two patients, one with osteitis fibrosa and the other with osteomalacia, significant biochemical, radiological, and histological improvements occurred, and total body calcium measured by in-vivo neutron activation analysis increased. In two patients, in whom there were no increases of whole-body calcium, neither biochemical improvement nor healing of bone lesions occurred during the study; in one of these patients the effect of 1-alpha-OHD3 on bone resorption may have contributed to loss of body calcium and deterioration of bone disease. 1-alpha-OHD3 may therefore be a valuable adjunct in the treatment of only some patients with renal osteodystrophy. Whole-body in-vivo neutron activation seems to provide a sensitive and non-invasive index of early response to treatment.

Full text

PDF
82

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blunt J. W., DeLuca H. F., Schnoes H. K. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry. 1968 Oct;7(10):3317–3322. doi: 10.1021/bi00850a001. [DOI] [PubMed] [Google Scholar]
  2. Brickman A. S., Coburn J. W., Norman A. W. Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. N Engl J Med. 1972 Nov 2;287(18):891–895. doi: 10.1056/NEJM197211022871801. [DOI] [PubMed] [Google Scholar]
  3. Care A. D., Sherwood L. M., Potts J. T., Jr, Aurbach G. D. Perfusion of the isolated parathyroid gland of the goat and sheep. Nature. 1966 Jan 1;209(5018):55–57. doi: 10.1038/209055a0. [DOI] [PubMed] [Google Scholar]
  4. Cohn S. H., Cinque T. J., Dombrowski C. S., Letteri J. M. Determination of body composition by neutron activation analysis in patient with renal failure. J Lab Clin Med. 1972 Jun;79(6):978–994. [PubMed] [Google Scholar]
  5. Fraser D. R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970 Nov 21;228(5273):764–766. doi: 10.1038/228764a0. [DOI] [PubMed] [Google Scholar]
  6. Gosling P., Robinson B. H., Sammons H. G. Changes in protein-bound calcium in the serum of haemodialysis patients. Clin Sci Mol Med Suppl. 1975 Jun;48(6):521–528. doi: 10.1042/cs0480521. [DOI] [PubMed] [Google Scholar]
  7. Henderson R. G., Russell R. G., Ledingham J. G., Smith R., Oliver D. O., Walton R. J., Small D. G., Preston C., Warner G. T. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet. 1974 Mar 9;1(7854):379–384. doi: 10.1016/s0140-6736(74)93149-3. [DOI] [PubMed] [Google Scholar]
  8. Lund B., Hjorth L., Kjaer I., Reimann I., Friis T., Andersen R. B., Sorensen O. H. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol. Lancet. 1975 Dec 13;2(7946):1168–1171. doi: 10.1016/s0140-6736(75)92656-2. [DOI] [PubMed] [Google Scholar]
  9. Mawer E. B., Taylor C. M., Backhouse J., Lumb G. A., Stanbury S. W. Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency. Lancet. 1973 Mar 24;1(7804):626–628. doi: 10.1016/s0140-6736(73)92197-1. [DOI] [PubMed] [Google Scholar]
  10. Moorhead J. F., Varghese Z., Tatler G. L., Baillod R. A., Wills M. R. Comparison of biochemical with radiological findings in renal osteodystrophy. Ann Clin Biochem. 1975 May;12(3):126–131. doi: 10.1177/000456327501200126. [DOI] [PubMed] [Google Scholar]
  11. Peacock M., Gallagher J. C., Nordin B. E. Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man. Lancet. 1974 Mar 9;1(7854):385–389. doi: 10.1016/s0140-6736(74)93150-x. [DOI] [PubMed] [Google Scholar]
  12. Stevens J., Thomas F. Alkaline phosphatase: reaction rate analysis at 340 nm. Clin Chim Acta. 1972 Mar;37:541–543. doi: 10.1016/0009-8981(72)90484-6. [DOI] [PubMed] [Google Scholar]
  13. Tucker G., 3rd, Gagnon R. E., Haussler M. R. Vitamin D 3 -25-hydroxylase: tissue occurrence and apparent lack of regulation. Arch Biochem Biophys. 1973 Mar;155(1):47–57. doi: 10.1016/s0003-9861(73)80008-6. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES